Lineage Therap(DE:BT3)
€0.97+0.00 (+7.17%)
DE:BT3
Lineage Therap earnings date
€0.97
At close:+0.00 (+7.17%)
Lineage Therap (BT3) Q2 2026 Earnings Report
1 Followers
DE:BT3 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.03
- Consensus EPS
- -EUR 0.03
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.12
DE:BT3 Q2 2026 Revenue Results
- Actual Revenue
- EUR 966.30K
- Expected Revenue
- EUR 1.67M
- Beat/Miss
- Missed by -EUR 698.74K
- YoY Revenue Growth
- -61.34%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
DE:BT3 Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:BT3 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BT3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -0.02- | 0 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.03-0.03 | -0.12 | 76.92% (+0.09) | |
| Aug 06, 2026 | 2026 (Q2) | -0.03-0.03 | -0.12 | 76.92% (+0.09) | |
| May 12, 2026 | 2026 (Q1) | -0.02-0.03 | -0.02 | -50.00% (-0.01) | |
| Mar 05, 2026 | 2025 (Q4) | -0.040.00 | -0.02 | 120.00% (+0.02) | |
| Nov 06, 2025 | 2025 (Q3) | -0.02-0.12 | -0.02 | -550.00% (-0.10) | |
| Aug 12, 2025 | 2025 (Q2) | -0.02-0.12 | -0.03 | -333.33% (-0.09) | |
| May 13, 2025 | 2025 (Q1) | -0.02-0.02 | -0.04 | 50.00% (+0.02) | |
| Mar 10, 2025 | 2024 (Q4) | -0.03-0.02 | -0.03 | 33.33% (+0.01) | |
| Nov 14, 2024 | 2024 (Q3) | -0.04-0.02 | -0.04 | 50.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
